The customer questioned the architect ca19-9 generated from one patient.The patient is an (b)(6) female with acute pneumonia and eating disorder but no history of cancer.A result of 4978 u/ml was generated back in (b)(6) along with a high crp which indicated an inflammation.A new sample from the same patient generated a result of 62.18 u/ml on (b)(6) and repeated at 74.57 u/ml.Another sample was tested on (b)(6) with a result of 7.11 u/ml, repeated at 13.17 u/ml.No treatment was administered to the patient between (b)(6).However, the patient died on (b)(6) due to myocardial infarction and acute circulatory failure.The customer did not allege a malfunction of the architect ca19-9 assay could have caused or contributed to the death of the patient.The physician suspected the patient to have a diagnosis of either lung cancer, pancreatic cancer or colon cancer.A medical assessment was obtained which indicated that the architect ca19-9 reagent did not cause or contribute to the death of the patient (given the information presented, it does not appear that the ca 19-9 results caused or contributed to the patient's myocardial infarction and acute circulatory failure).
|